TickerFactsScreenerDevelopers

ADMA BIOLOGICS, INC. (ADMA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $229.0K2011: $87.8K2012: $12.54M2013: $26.15M2014: $17.20M2015: $10.44M2016: $9.91M2017: $43.11M2018: $26.75M2019: $26.75M2020: $55.92M2021: $51.09M2022: $86.52M2023: $51.35M2024: $103.15M2025: $87.63M$87.63M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$87.63M-15.0%
2024$103.15M+100.9%
2023$51.35M-40.6%
2022$86.52M+69.4%
2021$51.09M-8.6%
2020$55.92M+109.0%
2019$26.75M-0.0%
2018$26.75M-37.9%
2017$43.11M+334.8%
2016$9.91M-5.0%
2015$10.44M-39.3%
2014$17.20M-34.2%
2013$26.15M+108.6%
2012$12.54M+14182.2%
2011$87.8K-61.7%
2010$229.0K—